Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi)
Launched by BEIJING TIANTAN HOSPITAL · Jul 23, 2023
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
The clinical trial titled "Detection of Microplastics and Nanoplastics in Neurosurgery Patients" is exploring whether tiny plastic particles, which are commonly found in our environment and food, can also be present in the bodies of patients undergoing neurosurgery. These particles, known as microplastics and nanoplastics, could potentially be found in samples such as blood, brain tissue, and tumors during surgery. The study aims to collect these samples from neurosurgery patients to determine if these plastic particles exist in their bodies, helping us understand the impact of plastic pollution on human health.
To be eligible for this study, participants must be between 18 and 80 years old and scheduled for any type of neurosurgery. If you decide to participate, you’ll be asked to provide biological samples during your surgery. The findings from this research could provide valuable insights into how plastic pollution affects patients and may help guide future health recommendations. It's important to note that participation is completely voluntary, and you can choose not to take part at any time.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18-80 years
- • Any type of neurosurgery
- Exclusion Criteria:
- • ·refusal of the patient to participate
About Beijing Tiantan Hospital
Beijing Tiantan Hospital, affiliated with Capital Medical University, is a leading medical institution in China renowned for its expertise in neurology, neurosurgery, and various other specialties. As a prominent clinical trial sponsor, the hospital is committed to advancing medical research and improving patient outcomes through innovative studies. With a focus on high-quality clinical trials, Beijing Tiantan Hospital adheres to rigorous ethical standards and regulatory requirements, fostering collaboration with academic institutions and industry partners to facilitate the development of cutting-edge therapies and interventions. Its state-of-the-art facilities and experienced research team enable the hospital to play a pivotal role in the global medical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Trial Officials
Runting Li, MD
Principal Investigator
Beijing Tiantan Hospital
Yitong Jia, MD
Principal Investigator
Beijing Tiantan Hospital
Ke Wang, MD
Principal Investigator
Beijing Tiantan Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported